0001225208-24-001958.txt : 20240213 0001225208-24-001958.hdr.sgml : 20240213 20240213172756 ACCESSION NUMBER: 0001225208-24-001958 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240209 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cordani David CENTRAL INDEX KEY: 0001318751 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 24630223 MAIL ADDRESS: STREET 1: THE CIGNA GROUP STREET 2: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 4 1 doc4.xml X0508 4 2024-02-09 0001739940 Cigna Group CI 0001318751 Cordani David 900 COTTAGE GROVE ROAD BLOOMFIELD CT 06002 1 1 Chairman & CEO 1 Common Stock, $.01 Par Value 2024-02-09 4 M 0 38065.0000 139.2200 A 367386.0000 D Common Stock, $.01 Par Value 2024-02-09 4 S 0 38065.0000 335.2193 D 329321.0000 D Common Stock, $.01 Par Value 2024-02-12 4 M 0 2073.0000 139.2200 A 331394.0000 D Common Stock, $.01 Par Value 2024-02-12 4 S 0 213.0000 335.3568 D 331181.0000 D Common Stock, $.01 Par Value 2024-02-12 4 S 0 644.0000 337.3712 D 330537.0000 D Common Stock, $.01 Par Value 2024-02-12 4 S 0 1216.0000 336.7600 D 329321.0000 D Common Stock, $.01 Par Value 2024-02-13 4 M 0 7462.0000 139.2200 A 336783.0000 D Common Stock, $.01 Par Value 1727.2938 I By 401(k) Common Stock, $.01 Par Value 99918.0000 I By GRAT Common Stock, $.01 Par Value 153801.0000 I By Trust Employee Stock Option (Right to Buy) 139.2200 2024-02-09 4 M 0 38065.0000 0.0000 D 2017-03-01 2026-03-01 Common Stock, $.01 Par Value 38065.0000 104736.0000 D Employee Stock Option (Right to Buy) 139.2200 2024-02-12 4 M 0 2073.0000 0.0000 D 2017-03-01 2026-03-01 Common Stock, $.01 Par Value 2073.0000 102663.0000 D Employee Stock Option (Right to Buy) 139.2200 2024-02-13 4 M 0 7462.0000 0.0000 D 2017-03-01 2026-03-01 Common Stock, $.01 Par Value 7462.0000 95201.0000 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. Reflects the transfer by the Reporting Person's grantor retained annuity trust of 113,677 shares on January 26, 2024 of common stock in respect of a payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust. Represents the weighted average price of the shares sold. The prices actually received ranged from $335.00 to $335.68 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $335.00 to $335.76 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $337.10 to $337.85 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents the weighted average price of the shares sold. The prices actually received ranged from $336.08 to $337.07 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan. This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. Exhibit List: EX-24 Power of Attorney poacordani.txt Matthew Arnold, attorney-in-fact 2024-02-13 EX-24 2 poacordani.txt POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, a Director and Officer of The Cigna Group, a Delaware corporation ("Cigna"), hereby makes, designates, constitutes and appoints NICOLE S. JONES, KARI KNIGHT STEVENS, ANDREA NELSON, JILL STADELMAN, SHERMONA MAPP AKOTIA and MATTHEW ARNOLD, each acting individually, as the undersigned's true and lawful attorneys-in-fact and agents, with full power and authority to act in the undersigned's capacity as a Director and Officer of The Cigna Group for and in the name, place and stead of the undersigned to execute and deliver: (A) in connection with the filing with the Securities and Exchange Commission pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934, both as amended, of: (i) Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, Forms 144 in accordance with Rule 144 promulgated under the Securities Act of 1933 and any and all other documents related thereto (including, but not limited to, Seller's Representation Letters) and to take further action as they, or any of them, deem appropriate in connection with the foregoing. Such attorneys-in-fact and agents, or any of them, are also hereby granted full power and authority, on behalf of and in the name, place and stead of the undersigned, to execute and deliver any and all such other documents, and to take further action as they, or any of them, deem appropriate in connection with the foregoing. The powers and authorities granted herein to such attorneys-in-fact and agents, and each of them, also include the full right, power and authority to effect necessary or appropriate substitutions or revocations. The undersigned hereby ratifies, confirms, and adopts, as his or her own act and deed, all action lawfully taken by such attorneys-in-fact and agents, or any of them, or by their respective substitutes, pursuant to the powers and authorities herein granted. This Power of Attorney with respect to Forms 3, 4, 5 and 144 shall remain in full force and effect until:, the undersigned no longer has responsibilities relating to Section 16 of the Securities Exchange Act of 1934 or Rule 144 promulgated under the Securities Act of 1933 with respect to the undersigned's beneficial ownership of securities of The Cigna Group, unless earlier revoked by the undersigned in a signed writing to each such attorney in fact. IN WITNESS WHEREOF, the undersigned has executed this document as of the 2nd day of January, 2024. __/s/ David M Cordani__________ Signature David M Cordani_______________ Print Name